Learn more about health conditions and diseases that are related to our areas of research.
Our business development team is actively engaged in developing relationships with potential partners and funding organizations for the advancement of shared research initiatives.
The Office of Technology Management and Commercialization manages the commercialization of discoveries that result from our collaborative medical research.
We’re partnering with 60° Pharmaceuticals to test furin, a human proteinase, as a drug target for the treatment of dengue fever, one of the most common infectious diseases in the tropics and subtropics.
Sanford-Burnham recently renewed its partnership with Takeda Pharmaceutical Company and Florida Hospital to find new treatments approaches for obesity.
The new collaboration combines Sanford-Burnham’s renowned scientific team and Intrexon’s proprietary discovery platforms to accelerate human induced pluripotent stem cell (iPSC) research.
We combine the creativity of an academic environment with the discipline
of industry to offer partners deep bench strength in fundamental,
pharmaceutical and biotech research.
- John C. Reed, M.D., Ph.D.
Donald Bren Chief Executive Chair
We invite you to explore partnering with Sanford-Burnham.
Senior Director, Business Development
Senior Director, Intellectual Property and Legal Affairs
Sanford-Burnham's Office of Technology Management and Commercialization (OTMC) manages the commercialization of discoveries that result from the Institute's world-class collaborative medical research. Our business development team is actively engaged in developing relationships with potential partners and funding organizations for the advancement of shared research initiatives.
The Institute has invested in state-of-art technologies to empower our translational research focus. These drug discovery cores are staffed with industry-savvy teams that are equipped to serve the biomedical research community.
Our multi-disciplinary approach provides partners with access to custom-designed teams that include academic investigators, clinical researchers, and in-house scientists with extensive pharmaceutical and biotechnology industry experience.
The OTMC's Business Development team facilitates collaborations, partnerships, contracts, and commercialization of technology. The Intellectual Property team manages the licensing of technology and material transfers.
Be alerted about breakthroughs
© Sanford-Burnham Medical Research Institute. All rights reserved.